Funding for this research was provided by:
Chengdu High-level Key Clinical Specialty Construction Project
Received: 15 September 2021
Accepted: 30 November 2021
First Online: 6 January 2022
: The study was approved by the Biomedical Ethics Review Committee of Peking University (IRB00001052-11015), and informed consent was obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests.